Wall Street analysts expect Sharps Compliance Corp. (NASDAQ:SMED) to report earnings of ($0.01) per share for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Sharps Compliance’s earnings, with estimates ranging from ($0.02) to ($0.01). Sharps Compliance reported earnings per share of ($0.05) in the same quarter last year, which suggests a positive year over year growth rate of 80%. The company is expected to announce its next quarterly earnings results on Wednesday, April 24th.

According to Zacks, analysts expect that Sharps Compliance will report full year earnings of $0.06 per share for the current fiscal year, with EPS estimates ranging from $0.04 to $0.07. For the next fiscal year, analysts anticipate that the business will post earnings of $0.15 per share, with EPS estimates ranging from $0.08 to $0.35. Zacks’ EPS averages are an average based on a survey of research analysts that cover Sharps Compliance.

Sharps Compliance (NASDAQ:SMED) last posted its earnings results on Wednesday, January 23rd. The industrial products company reported $0.05 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.03 by $0.02. The firm had revenue of $12.39 million during the quarter, compared to the consensus estimate of $11.40 million. Sharps Compliance had a negative net margin of 0.13% and a negative return on equity of 0.21%. During the same quarter in the prior year, the company earned $0.01 EPS.

SMED has been the subject of a number of research analyst reports. Barrington Research set a $5.00 target price on shares of Sharps Compliance and gave the stock a “buy” rating in a research report on Thursday, October 25th. Zacks Investment Research raised shares of Sharps Compliance from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 7th. Three analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $4.33.

SMED opened at $3.81 on Wednesday. The company has a market cap of $61.47 million, a P/E ratio of -95.25, a price-to-earnings-growth ratio of 3.54 and a beta of 0.21. Sharps Compliance has a 1 year low of $2.97 and a 1 year high of $5.15. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.63 and a quick ratio of 2.02.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SMED. Ingalls & Snyder LLC boosted its holdings in Sharps Compliance by 492.9% in the 3rd quarter. Ingalls & Snyder LLC now owns 351,268 shares of the industrial products company’s stock worth $1,212,000 after acquiring an additional 292,018 shares during the period. Quantum Capital Management boosted its holdings in Sharps Compliance by 82.7% in the 3rd quarter. Quantum Capital Management now owns 484,456 shares of the industrial products company’s stock worth $1,671,000 after acquiring an additional 219,351 shares during the period. Wells Fargo & Company MN boosted its holdings in Sharps Compliance by 16.0% in the 3rd quarter. Wells Fargo & Company MN now owns 321,500 shares of the industrial products company’s stock worth $1,109,000 after acquiring an additional 44,400 shares during the period. Lapides Asset Management LLC boosted its holdings in Sharps Compliance by 24.8% in the 3rd quarter. Lapides Asset Management LLC now owns 163,200 shares of the industrial products company’s stock worth $563,000 after acquiring an additional 32,400 shares during the period. Finally, North Star Investment Management Corp. boosted its holdings in Sharps Compliance by 10.0% in the 3rd quarter. North Star Investment Management Corp. now owns 260,425 shares of the industrial products company’s stock worth $898,000 after acquiring an additional 23,775 shares during the period. Hedge funds and other institutional investors own 21.07% of the company’s stock.

About Sharps Compliance

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.

Recommended Story: How Investors Can Profit from Options Trading

Get a free copy of the Zacks research report on Sharps Compliance (SMED)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sharps Compliance (NASDAQ:SMED)

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.